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for early rejection after renal 
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Background: The T-cell composition within the lymph node (LN) of end-stage renal 
disease (ESRD) patients differs from the composition within the circulation. Activation 
of the alloreactive T-cell response within secondary lymphoid organs is important after 
organ transplantation. However, to date no data are present on LN T-cell subsets and 
the risk for acute rejection after kidney transplantation.
Methods: T cells from LNs of ESRD patients were analyzed for frequency of recent thy-
mic emigrants, relative telomere length, expression of differentiation markers, and were 
related to the development of early acute rejection (EAR), occurring within 3 months 
after renal transplantation (RT). Furthermore, the alloreactive potential of mononuclear 
cells isolated from the LN and peripheral blood of 10 patients was analyzed. Measures 
of alloreactive potential included proliferation, cytokine production, frequencies of 
interferon-gamma-producing cells, and the presence of cytotoxic molecules.
results: Patients with EAR were younger (p =  0.019), cytomegalovirus-seropositive 
(p = 0.037) and usually received dialysis prior to RT (p = 0.030). Next to this, patients 
with EAR showed a lower CD4:CD8 ratio (p = 0.027) within the LN. T cells from the 
LN were similar with regard to alloreactive capacity compared with those within the 
circulation. Univariate regression analysis showed that the CD4:CD8 ratio (OR: 0.67, 
p = 0.039), patient age (OR: 0.93, p = 0.024), and preemptive RT (OR: 0.11, p = 0.046) 
were associated with EAR. After a multivariate analysis, only the CD4:CD8 ratio (OR: 
0.58, p = 0.019) and preemptive RT (OR:0.05, p = 0.012) were associated with EAR.
conclusion: A lower CD4:CD8 ratio in the LN is associated with a higher risk for the 
development of rejection within 3 months after RT.
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inTrODUcTiOn
The composition and function of the T-cell compartment in patients prior to renal transplantation 
(RT) may affect the risk for subsequent acute rejection and infection after transplantation (1–7). For 
instance, aging-related expansion of highly differentiated T cells within peripheral blood (PB), such 
as CD8+ effector memory CD45RA+ (EMRA) T cells or CD4+CD28null T cells, is associated with a 
lower risk for early acute rejection (EAR) after RT (1, 2).
TaBle 1 | Patient characteristics.
rT patients  
(n = 38)
no rejection 
(n = 27) (71%)
rejection 
(n = 11) (29%)
p
Age recipient 60 (51–66) 47 (37–58) 0.019
Age donor 51 (42–61) 63 (50–69) 0.129
Male gender recipient 17 (63%) 7 (64%) >0.999
CMV-seropositivity recipient 17 (63%) 11 (100%) 0.037
cMV-serostatus donor/recipient
−/− 6 (29%) 0 (0%) 0.154
−/+ 7 (26%) 7 (64%) 0.061
+/− 4 (15%) 0 (0%) 0.303
+/+ 10 (37%) 4 (36%) >0.999
Mismatch HLA class I 3 (2–4) 3 (2–4) 0.727
Mismatch HLA class II 1 (1–2) 1 (1–2) 0.824
Mismatch HLA class I and II 4 (4–5) 5 (3–5) 0.949
PRA current (%) 0 (0–4) 0 (0–33) 0.446
PRA historic (%) 4 (0–29) 6 (0–73) 0.727
Number of RT 1 (1–1) 1 (1–1) >0.999
Warm ischemia time (min) 17 (13–22) 23 (20–27) 0.045
Living donor transplant 22 (81%) 8 (73%) 0.667
cause of cKD
Nephrosclerosis/atherosclerosis/
hypertension
6 (22%) 5 (45%) 0.238
Primary glomerulopathies 3 (11%) 2 (13%) 0.615
Diabetes 7 (26%) 0 (0%) 0.084
Polycystic kidney disease 6 (22%) 2 (18%) >0.999
Other 2 (7%) 1 (9%) >0.999
Unknown 3 (11%) 1 (9%) >0.999
Pre-emptive RT 13 (48%) 1 (9%) 0.030
Genetically related RT 1 (4%) 1 (9%) 0.501
acute rejection type
Cellular rejection 7 (64%)
Antibody-mediated rejection 4 (36%)
Data are presented as medians (interquartile range) or as numbers (percentages).
CKD, chronic kidney disease; CMV, cytomegalovirus; HLA, human leukocyte antigen; 
PRA, panel reactive antibody; RT, renal transplantation.
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However, T cells within PB are only one of the cell popula-
tions that play a role in allograft rejection. Another compart-
ment which may have a significant role in the development 
of acute rejection is the lymph nodes (LNs). Early after organ 
transplantation, the direct pathway of alloantigen recognition 
plays the most important part in the initiation of the alloreactive 
response (8). One of the key events for this response is migra-
tion of donor-derived dendritic cells to LNs of the host, which 
is followed by activation of alloreactive T  cells (8, 9). Next to 
this, a semi-direct pathway is also being described (8, 10), which 
involves transfer of intact MHC:peptide complexes from donor 
antigens presenting cells (APCs) to host APCs, and simultane-
ous presentation of the processed antigens to CD4+ T cells in an 
indirect manner and the intact complexes to CD8+ T cells in a 
direct manner (10, 11). These pathways show the importance of 
the T-cell composition within LNs with regard to development 
of rejection.
The T-cell composition of LN differs substantially from PB as 
T-cell subsets may or may not be able to migrate to LNs. We and 
others have studied the T-cell composition of the LN of end-stage 
renal disease (ESRD) patients and found that highly differentiated 
T cells were virtually absent from LNs, while they were present 
within PB (12, 13). Whether the LN T-cell composition and 
alloreactivity are associated with development of acute rejection 
after RT has not been studied thus far.
The aim of this study was therefore to investigate whether 
phenotypical T-cell characteristics within LNs showed an asso-
ciation with development of rejection within 3  months after 
RT. Furthermore, we have also investigated the alloreactive 
potential within LN and PB, to assess whether the differences 
in T-cell composition contributed to this alloreactive potential. 
The alloreactive potential was assessed by performing mixed 
lymphocyte reactions (MLRs) and analyzing proliferation, 
cytokine production, frequencies of interferon-gamma (IFN-
γ)-producing cells and presence of cytotoxic molecules within 
supernatants.
MaTerials anD MeThODs
study Population
Patients prior to RT in the period from August 2015 to March 
2016 were suitable for participation. Each patient gave writ-
ten informed consent to take part in this study. The study was 
approved by the Medical Ethical Committee of the Erasmus MC 
(MEC number 2015-301) and was conducted in accordance with 
the Declaration of Helsinki and the Declaration of Istanbul.
Clinical variables were assessed as shown in Table 1, includ-
ing age of the recipient and donor, gender, CMV-seropositivity, 
human leukocyte antigen (HLA) class I and class II mismatches, 
current and historical panel reactive antibody (PRA) scores, 
number of RTs, warm ischemia time, number of living donor 
transplants, cause of chronic kidney disease, preemptive RT 
(defined as receiving a kidney before initiation of renal replace-
ment therapy), number of related RT (receiving a kidney 
from a genetically related donor), and type of rejection. The 
HLA-typing was assessed according to international standards 
(American Society for Histocompatibility and Immunogenetics/
the European Federation for Immunogenetics) using serologic 
and DNA-based techniques. The PRAs were determined at the 
laboratory of the blood bank in Leiden, the Netherlands.
Early acute rejection was defined as development of biopsy-
proven acute allograft rejection according to the Banff criteria 
(14, 15) within 3 months after RT.
PBMc and lnMc isolation
Peripheral blood mononuclear cells (PBMCs) and lymph node 
mononuclear cells (LNMCs) were isolated as described previ-
ously (12). Briefly, PBMCs were isolated from heparinized blood 
samples by using Ficoll-Paque Plus (GE healthcare, Uppsala, 
Sweden). Blood was drawn from renal transplant recipients 1 day 
before RT.
The waste material from renal transplant recipients removed 
during the implantation of the renal allograft was used to collect 
iliac LNs. The LNs were cut into small pieces and transferred 
onto a 70-µm sieve. A cell suspension was obtained after mash-
ing the small pieces through this sieve. The cell suspension was 
then washed multiple times to eliminate remaining fat tissue. 
The isolated PBMCs and LNMCs were stored at −150°C with a 
minimum amount of 10 × 106 cells/vial. Median yield of the LN 
amounted to 20 × 106 cells.
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T-cell Differentiation status
Whole blood and freshly isolated LNMCs were used to assess 
T-cell differentiation status by flowcytometry. Differentiation 
status was based upon the study by Sallusto et  al. (16), as 
described in detail previously (17). Briefly, expression of 
CD45RO and CCR7 was used to determine naïve and memory 
T-cell populations. Memory T-cell subsets were further defined 
as central memory (CM) T cells (CD45RO+CCR7+ T cells), effec-
tor memory (EM) T cells (CD45RO+CCR7− T cells), and EMRA 
T  cells (CD45RA+CCR7− EM T  cells) (16). In addition, CD28 
expression was analyzed as this is lost upon T-cell differentia-
tion (18–21). Cells were stained as described previously (2), and 
were measured on the FACSCanto II (BD) and analyzed with the 
fluorescence-activated cell sorting (FACS) Diva software version 
6.1.2 (BD).
To dissect T  cells into early- and late-differentiated cells, 
expression of CD28, CD27, CD57, and PD-1 was also analyzed. 
Naïve and CM T cells express CD28 and CD27. EM and EMRA 
T  cells progressively lose expression of these molecules [CD4+ 
T cells first lose CD27 and then CD28, while the opposite is true 
for CD8+ T cells (22–24)] and express CD57 and PD-1 (25–28). 
Thus, early-differentiated T cells were defined as CD28+CD27+, 
CD28+PD-1−, and CD28+CD57− T  cells, while CD28nullCD27−, 
CD28nullPD-1+, and CD28nullCD57+ T cells were defined as late-
differentiated T cells. This measurement was performed on the 
Navios flow cytometer (Beckman Colter) and collected data were 
evaluated with the Kaluza software version 1.3 (Beckman Colter). 
T  cells were analyzed with DuraClone IM T-cell subsets tubes 
(Beckman Colter) as described previously (12).
relative Telomere length (rTl)
Relative telomere length of CD4+ and CD8+ T  cells was deter-
mined by using flow fluorescent in situ hybridization on thawed 
PBMCs and LNMCs, as described in detail previously (17).
assessment of rTes Using cD31 and 
Trec content
Recent thymic emigrants (RTEs) were defined as naïve T  cells 
expressing CD31 and were assessed by flow cytometry, as 
described previously (29). T-cell receptor excision circle (TREC) 
content was determined using 1 × 106 snap-frozen PBMCs and 
LNMCs. DNA was isolated from these snap-frozen samples 
and TREC content was detected using quantitative polymerase 
chain reaction as described previously (30). The TREC content is 
depicted as 1/ΔCT.
allogeneic stimulation
Peripheral blood mononuclear cells and lymph node mononu-
clear cells from renal transplant recipients (responders) were 
thawed and rested overnight. Then PBMCs and LNMCs were 
labeled with carboxyfluorescein succinimidyl ester (CFSE) 
(Molecular Probes®, Leiden, the Netherlands) according to man-
ufacturer’s instructions and stimulated in triplicate at 5 × 104/
well with irradiated PBMCs (40  Gy) of their corresponding 
donor, at a 1:1 ratio for 6 days. As a negative control, responders 
were stimulated with their own irradiated PBMCs or LNMCs 
(autologous stimulation). Responder cells were stimulated with 
phytohemagglutinin (PHA) 5 µg/ml to examine their maximum 
proliferative potential. On day 6, wells of the same condition 
were pooled and supernatant stored at −80°C. Proliferation 
was analyzed by measuring CFSE dilution and determining the 
frequency of CFSE− cells. For this purpose, cells were stained 
using the following antibodies: AmCyan-labeled anti-CD3 
(BD), pacific blue (PacB)-labeled anti-CD4 (BD), APC-Cy7-
labeled anti-CD8 (BD), phycoerythrin (PE)-Cy7-labeled anti-
CCR7 (BD Pharmigen), APC-labeled anti-CD45RO (BD), and 
PE-labeled anti-CD28 (BD). A dump-channel was applied to 
exclude unwanted cells from the analysis, by co-staining cells 
for the live-dead marker 7-AAD, peridin chlorophyll protein 
(PerCP)-labeled anti-CD19 (BD), PerCP-Cy5.5-labeled anti-
CD56 (Biolegend), and PerCP-labeled anti-CD14 (BD) (Figure 
S1 in Supplementary Material). Samples were measured on the 
FACSCanto II (BD) and analyzed using FACS Diva software 
version 6.1.2 (BD).
analysis of cytokine and granzyme B 
Production
Concentrations of IFN-γ, tumor necrosis factor-alpha (TNF-α), 
and granzyme B were determined from collected supernatants. 
These supernatants were analyzed with the human cytometric 
bead array (CBA) flex set (BD) according to manufacturer’s 
instructions. Briefly, a standard curve for each analyte using a 
four-parameter logistic regression analysis was created. This 
curve was based upon standards with fixed concentrations of 
each analyte and their corresponding median fluorescence 
intensities (MFIs). Then, MFIs of the various analytes within the 
samples were converted to concentrations (pg/mL). Samples were 
measured on the FACS Canto II (BD) and concentrations were 
determined with GraphPad Prism 5 (CA, USA).
iFn-γ elisPOT assay
Frequencies of IFN-γ-producing cells (spots/100,000 cells) 
following autologous, allogeneic, or PHA stimulation were 
measured with an Enzyme-Linked ImmunoSpot (ELISPOT) 
assay (U-CyTech, Utrecht, The Netherlands). During the day 
1, the ELISPOT plate was coated with the antibody and incu-
bated overnight. The same day cells were thawed and rested 
overnight. The following day, the assay plate was blocked using 
a blocking buffer and incubated for 1 h at 37°C. After the plate 
was washed with phosphate-buffered saline (PBS), cells were 
pipetted into wells and stimulated in triplicate, as described 
earlier, for 1 day. Thereafter, plates were washed first with PBS 
and then with PBS-Tween. Spots were made visible according 
to manufacturer’s instructions. Spots were analyzed using the 
ELISpot reader (Bioreader®-600V, BIO-SYS GmbH, Karben, 
Germany).
statistical analysis
Variables are presented as medians with interquartile ranges. 
Differences between paired samples (PB and LN from the same 
patient) were analyzed using the Wilcoxon signed-rank test. 
Differences between continuous variables from two independent 
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groups were assessed with the Mann–Whitney U test. Differences 
between categorical variables were analyzed either with the 
Pearson’s chi-squared test or with the Fisher’s exact test depend-
ing on the expected values in any of the cells of a contingency 
table. Associations between rejection and the assessed parameters 
were analyzed using a binary logistic regression analysis. The 
significance level (p-value) was two-tailed and a value of α = 0.05 
was used. Statistical analyses were performed using SPSS® version 
21.0 for Windows® (SPSS Inc., IL, USA) and GraphPad Prism 5 
(CA, USA). Figures were created with GraphPad Prism 5 (CA, 
USA).
resUlTs
Patient characteristics
Patient characteristics (n =  38) are shown in Table  1. Median 
patient age was 58  years and median donor age was 55  years. 
Most of the patients underwent an RT for the first time (82%), 
while 18% underwent a transplantation for the second time. Most 
common cause of ESRD was nephrosclerosis/atherosclerosis/
hypertension (29%) followed by polycystic kidney disease (21%), 
together accounting for half of the cases. Overall, 24 (63%) 
patients received dialysis treatment prior to RT. Eleven of the 
38 patients (29%) developed an EAR. Majority of the rejections 
were classified as cellular rejection (64%) and the remaining 
as antibody-mediated rejection. Median patient age was sig-
nificantly younger within the rejectors compared with the non-
rejectors (47 vs. 60, p < 0.019). All patients who developed an 
EAR were CMV-seropositive, while 63% of the non-rejectors was 
CMV-seropositive (p = 0.037). Median warm ischemia time was 
longer for the rejectors compared with the non-rejectors (23 min 
vs. 17  min, p =  0.045). Majority of the rejectors had dialysis 
prior to RT (91%), while 52% of the non-rejectors received this 
therapy (p = 0.030). Immunological risk factors like PRA score, 
HLA mismatches, or unrelated donor transplantation were not 
different between the two groups.
T-cell composition of the ln Prior to rT 
showing an association with ear
Figures 1 and 2 show the T-cell differentiation status of CD4+ and 
CD8+ T cells within the LNs of the rejectors and non-rejectors. 
Median frequency of CD4+ T cells prior to RT is significantly lower 
(p = 0.014) and median frequency of CD8+ T cells is significantly 
higher (p = 0.019) within the rejectors (Figures 1A,B). This led 
to a significantly lower CD4:CD8 ratio in LNs of patients with 
EAR (3.4 vs. 5.7, p = 0.027) (Figure 1C). Furthermore, median 
frequencies of CD4+ EM T cells and CD4+CD28null T cells were 
significantly higher within the rejectors (p = 0.044 and p = 0.008, 
respectively) (Figures 2C,G). But overall, median percentage of 
CD4+CD28null T cells remained low in both groups (0.8 vs. 1.5%). 
No other significant differences were observed for the other CD4+ 
or CD8+ T-cell subsets.
Assessment of T-cell differentiation status can be further 
refined by differential expression levels of CD27, CD57, and PD-1 
in combination with CD28. However, this approach did not show 
any differences between the two groups (Table 2).
In summary, a lower CD4:CD8 ratio was associated with 
rejection.
rTl, rTes, and Trec content in the ln 
not associated with rejection
The telomere length is indicative of T-cell replicative history, while 
CD31 expression on naïve T cells and TREC content are a measure 
of thymic output of naïve T cells. These parameters are strongly 
associated with the age and therefore a measure of the biological 
age of the T-cell system (31–36). Figure 3 demonstrates the RTL of 
T cells, RTE frequency, and the TREC content in LNs between the 
rejectors and non-rejectors. RTL of CD4+ and CD8+ T cells was 
similar between the two groups (Figures 3A,B). Also, no differ-
ences were observed for CD4+ and CD8+ RTEs between rejection 
and no rejection (Figures 3C,D). Finally, the TREC content was 
also not associated with development of rejection (Figure 3E).
a lower cD4:cD8 ratio within the ln and 
Dialysis Prior Transplantation associated 
with rejection
Table 3 shows a univariate regression analysis of the significant 
clinical and immunological parameters with development of 
EAR. This univariate analysis showed that a higher CD4:CD8 
ratio was associated with a lower risk for EAR (OR  =  0.67, 
p = 0.039). Next to this, an older patient age and preemptive RT 
were also associated with a lower risk for rejection (OR = 0.93, 
p = 0.024; OR = 0.11, p = 0.046, respectively). Then these param-
eters were put into a multivariate regression analysis for a first 
model (Table 4). This showed that age was not associated with 
development of EAR. On the other hand, a higher CD4:CD8 
ratio showed a tendency for a lower risk for rejection (OR = 0.63, 
p = 0.053), while preemptive RT still showed a significant associa-
tion with development of EAR (OR = 0.06, p = 0.023). Taking the 
parameter “age” out of the equation showed a second model with 
significant associations (Table 4). A higher CD4:CD8 ratio and 
preemptive RT were both associated with a lower risk for EAR 
(OR = 0.58, p = 0.019; OR = 0.05, p = 0.012, respectively).
Thus, a lower CD4:CD8 ratio in the LN and receiving dialysis 
prior to transplantation increases the risk for the development of 
rejection after transplantation.
T cells from the ln and PB Proliferating 
similarly upon allogeneic stimulation
Median frequency of proliferating CD4+ T  cells from the LN 
rose significantly from 2.4 to 45.0% (p = 0.002) upon allogeneic 
stimulation (Figure 4A), and that of CD4+ T cells from the PB 
increased from 2.1 to 39.3% (p = 0.004) (Figure 4B). Within the 
proliferating CD4+ T  cells, majority of the cells were memory 
T cells (mainly CM) (Figures 4A,B). The CD28+ T-cell fraction 
was the main proliferating fraction within proliferating CD4+ 
T  cells in PB and LN (>99.0% proliferation in both compart-
ments) (Figures 4A,B).
The CD8+ T cells showed similar results compared with the 
CD4+ T  cells. Median frequency of proliferating CD8+ T  cells 
from the LN rose significantly from 1.4 to 22.9% (p =  0.004) 
upon allogeneic stimulation (Figure 4C) and median frequency 
FigUre 1 | CD4+ and CD8+ T-cell subsets in the lymph node between rejection and no rejection groups. (a) Frequencies of CD4+ T cells and (B) CD8+ T cells, 
(c) CD4:CD8 ratio, (D) frequencies of CD4+ naïve T cells, (e) CD8+ naïve T cells, (F) CD4+ memory T cells, and (g) CD8+ memory T cells within the lymph nodes are 
shown between the no rejection and rejection groups. Data are presented with individual percentages and medians or bars with interquartile range and medians. 
Significant differences were calculated and shown (*p < 0.05, **p ≤ 0.01, ***p ≤ 0.001).
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of CD8+ T cells from PB increased from 0.6 to 29.9% (p = 0.002) 
(Figure 4D). CD8+ memory T cells comprised the largest frac-
tion within proliferating CD8+ T cells in both LN and PB, with 
CM T cells also being the major contributor within this fraction 
(Figures 4C,D). The CD28+ T-cell fraction was again the main 
proliferating fraction within proliferating CD8+ T cells in LN and 
PB (Figures 4C,D).
Comparing the frequency of proliferating T  cells upon 
alloreactive stimulation between LN and PB showed no differ-
ences except for CD8+CD28null T cells within proliferating CD8+ 
T  cells. Median frequency of these cells within LN amounted 
to 0.3%, while this was 2.9% within PB (p =  0.037), which is 
probably due to the higher presence of these cells within PB 
compared with LN.
FigUre 2 | Memory CD4+ and CD8+ T-cell subsets and CD28 expression in the lymph node between rejection and no rejection groups. (a) Frequencies of CD4+ 
CM T cells, (B) CD8+ CM T cells, (c) CD4+ EM T cells, (D) CD8+ EM T cells, (e) CD4+ EMRA T cells, (F) CD8+ EMRA T cells, (g) CD4+CD28null T cells, and (h) 
CD8+CD28null T cells within the lymph nodes are shown between the no rejection and rejection groups. Data are presented with individual percentages and medians. 
Significant differences were calculated and shown (*p < 0.05, **p ≤ 0.01, ***p ≤ 0.001). CM, central memory; EM, effector memory; EMRA, effector memory 
CD45RA+.
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Polyclonal stimulation with PHA induced >95% proliferation 
of CD4+ T  cells and CD8+ T  cells from both compartments, 
although this response was significantly higher in CD4+ and 
CD8+ T cells from LN (p = 0.037 for both subsets). The functional 
assays could not be performed in all patients as the yield of cells 
from the LN was not sufficient enough in some cases. For this 
reason, the number of patients with EAR included in this part 
of the study was too low (n = 3) for adequate comparison with 
patients without EAR.
In conclusion, the alloreactive potential is not different 
between T  cells from LN and PB, but T  cells from LN show a 
slightly higher proliferative potential in response to PHA.
TaBle 2 | CD4+ and CD8+ T-cell differentiation status in lymph node with regard 
to the development of rejection.
n no rejection n rejection p
cD4+
CD4+CD28+CD27+ (%) 25 93.8 (91.6–96.6) 8 93.8 (81.1–94.7) 0.578
CD4+CD28nullCD27− (%) 25 0.3 (0.1–0.6) 8 0.2 (0.1–0.8) 0.951
CD4+CD28+PD-1− (%) 25 73.5 (64.0–82.0) 8 76.3 (72.0–80.4) 0.665
CD4+CD28nullPD-1+ (%) 25 0.4 (0.2–0.9) 8 0.5 (0.3–1.2) 0.578
CD4+CD28+CD57− (%) 25 97.6 (95.3–98.6) 8 97.0 (96.5–97.7) 0.272
CD4+CD28nullCD57+ (%) 25 0.1 (0.0–0.2) 8 0.1 (0.0–0.2) 0.885
cD8+
CD8+CD28+CD27+ (%) 25 89.6 (84.1–93.3) 8 90.4 (78.8–92.2) 0.789
CD8+CD28nullCD27− (%) 25 1.9 (1.0–2.6) 8 1.7 (1.0–6.5) 0.789
CD8+CD28+PD-1− (%) 25 62.2 (49.5–75.1) 8 66.9 (45.8–75.1) 0.853
CD8+CD28nullPD-1+ (%) 25 2.4 (1.6–5.2) 8 2.6 (1.6–4.8) 0.951
CD8+CD28+CD57− (%) 25 87.4 (80.2–91.0) 8 86.3 (75.5–88.8) 0.374
CD8+CD28nullCD57+ (%) 25 1.5 (1.0–2.3) 8 1.5 (0.9–4.3) 0.757
Data are presented as medians (interquartile range).
FigUre 3 | RTL, RTE frequency and TREC content in the lymph node between rejection and no rejection groups. The RTL of (a) CD4+ T cells and (B) CD8+ 
(T cells) within the lymph nodes between the no rejection and rejection groups are shown. Frequencies of (c) CD4+ and (D) CD8+ RTEs (CD31+ naïve T cells) within 
the lymph nodes between the no rejection and rejection group are shown. (e) The TREC content (1/ΔCT) within the lymph nodes between the no rejection and 
rejection group is shown. Data are shown as individual points and medians. Significant differences were calculated and shown (*p < 0.05, **p ≤ 0.01, ***p ≤ 0.001). 
RTEs, recent thymic emigrants; RTL, relative telomere length; TREC, T-cell receptor excision circle.
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iFn-γ elisPOT showing no Differences 
between ln and PB, but iFn-γ and 
granzyme B Production by lnMcs  
lower than PBMcs after 6 Days of 
allogeneic stimulation
Frequency of IFN-γ-producing LNMCs increased significantly 
after allogeneic stimulation (p = 0.034), while a similar tendency 
was seen for PBMCs (p =  0.083). However, median amount of 
spots remained low after allogeneic stimulation (3.5/1 × 105 for 
the LN and 6/1 × 105 for the PB). Furthermore, there were no sig-
nificant differences between the two different compartments after 
allogeneic stimulation (Figure 5A). Stimulation with PHA showed 
a significantly higher IFN-γ secretion by PBMCs compared with 
T cells within LNMCs (256/1 × 105 vs. 126/1 × 105, p = 0.047).
After allogeneic stimulation of LNMCs and PBMCs for 
6 days, concentrations of TNF-α, IFN-γ and granzyme B in the 
TaBle 4 | Multivariate regression analysis between rejection and immunological 
and clinical parameters.
Or 95% ci p
Model 1
CD4:CD8 ratio 0.63 0.39–1.01 0.053
Age recipient 0.97 0.90–1.04 0.393
Preemptive RT 0.06 0.01–0.68 0.023
Model 2
CD4:CD8 ratio 0.58 0.36–0.92 0.019
Preemptive RT 0.05 0.00–0.51 0.012
RT, renal transplantation.
TaBle 3 | Univariate regression analysis between rejection and immunological 
and clinical parameters.
Or 95% ci p
CD4+ T cells (%) 0.95 0.90–1.00 0.062
CD4+ EM T cells (%) 1.02 0.98–1.06 0.314
CD4+CD28null T cells (%) 1.30 0.86–1.95 0.216
CD4:CD8 ratio 0.67 0.45–0.98 0.039
CD8+ T cells (%) 1.08 1.00–1.16 0.057
Age recipient 0.93 0.88–0.99 0.024
CMV-seropositivity recipient 0.00 0.00–N/A 0.999
Warm ischemia time (min) 1.06 0.96–1.16 0.241
Preemptive RT 0.11 0.01–0.96 0.046
CMV, cytomegalovirus; EM, effector memory; RT, renal transplantation; N/A, not 
available.
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FigUre 4 | Proliferation of CD4+ and CD8+ T cells from the lymph node and peripheral blood after allogeneic stimulation. Frequencies of proliferating CD4+ T cells 
within (a) the lymph node and (B) the peripheral blood are shown after allogeneic stimulation. Frequencies of proliferating CD8+ T cells within (c) the lymph node 
and (D) the peripheral blood are shown after allogeneic stimulation. Each graph is divided into four parts marked with the dotted lines. From left to right: the total 
proliferating T-cell population is shown, which then is subdivided into naïve and memory T cells in the second portion, the third portion shows the subdivision of the 
memory T-cell population into CM, EM, and EMRA T cells, and the fourth portion shows the subdivision of the total T-cell population into CD28+ and CD28null T cells. 
Frequencies are presented with bars and medians. CM, central memory; EM, effector memory; EMRA, effector memory CD45RA+.
supernatants were significantly increased. LNMCs had a lower 
production of TNF-α (p  =  0.065) (Figure  5B), IFN-γ, and 
granzyme B compared with PBMCs (p = 0.020 and p = 0.049, 
respectively) (Figures  5C,D). Interestingly, amount of IFN-γ 
spots after allogeneic stimulation for 1 day correlated significantly 
with production of IFN-γ by LNMCs as well as PBMCs after 
6 days (ρ = 0.88, p = 0.001 and ρ = 0.64, p = 0.048, respectively).
Thus, production of TNF-α, IFN-γ, and granzyme B by LNMCs 
and PBMCs increases after allogeneic stimulation. However, 
generation of these products is lower by LNMCs than by PBMCs.
DiscUssiOn
This study has investigated the relation between T-cell charac-
teristics of the LN and acute rejection after RT for the first time. 
Surprisingly, a lower CD4:CD8 ratio in LNs was significantly 
associated with a higher risk for rejection. Studies have shown 
that CD8+ T  cells play an important role in allograft rejection 
(37, 38). Antigen presenting cells can present the alloantigen to 
CD4+ and CD8+ T  cells that are present within the LN, which 
will lead to activation of these cells. Having a lower CD4:CD8 
ratio might tip the balance toward a more cytotoxic profile, which 
could promote allograft rejection.
A study by Ford et  al. has shown in a murine skin graft 
model that a high initial frequency of antigen-specific CD8+ 
T cells resulted in development of CD8+ T cells which were able 
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to produce multiple cytokines and were more prone to escape 
co-stimulation blockade (39). Next to this, a study by Shenoy 
et al. showed that a lower CD4:CD8 ratio in bronchus-associated 
lymphoid tissue was associated with a higher frequency of acute 
rejections within 1 year after lung transplantation (40). Thus, 
having a high initial frequency of CD8+ T cells in LNs could lead 
to a higher chance for presence of alloreactive CD8+ T cells with 
increasing the risk for rejection.
It is known that alloantigen recognition can occur via direct 
or indirect pathways (8), but next to this a semi-direct path-
way is also being described (8, 10). This semi-direct pathway 
involves transfer of intact MHC:peptide complexes from donor 
APCs to host APCs and also the processing of antigens by host 
APCs (10). The host APCs can then simultaneously present the 
processed antigens to CD4+ T cells in an indirect manner, while 
they present the intact complexes to CD8+ T  cells in a direct 
manner (10, 11). At the same time, CD4+ T  cells can provide 
help to CD8+ T cells to activate them (10). It has been shown 
that CD4+ T cells which are activated by the indirect pathway 
can successfully enhance direct pathway CD8+ T-cell responses 
(41). As the direct pathway is the most important pathway in 
the initiation of alloreactive responses (8), a higher frequency of 
CD8+ T cells within LNs prior to transplantation will increase 
the possibility for allorecognition by the direct and also the 
semi-direct pathway.
Next to this, we have found that younger patients have a 
higher risk for EAR. Even though this finding was not significant 
after a multivariate analysis, it still showed an important differ-
ence between the rejectors and non-rejectors after a univariate 
analysis. This association between a younger age and an increased 
risk for rejection has also been found by previous studies (42, 43). 
An aged immune system in the older patients may underlie the 
reduced risk for rejection. In addition, ESRD patients undergo 
uremia-associated premature aging of their T-cell system 
(17, 29, 30), which further impairs the alloreactivity of their 
immune system. For this reason, we have studied in detail the 
relation between several immune parameters of T-cell aging and 
clinical outcome after RT. In particular, the increased presence of 
highly differentiated CD8+ EMRA T cells or CD4+CD28null T cells 
in the circulation was associated with a decreased risk for acute 
rejection but no other parameters such as telomere length and 
thymic output of naïve T cells (1, 2). In this study, we did not find 
an association between all tested immune parameters of T-cell 
aging and acute rejection. The absence of highly differentiated 
T cells within the LN is most likely the reason that we also could 
not relate the presence of these cells to acute rejection (12).
Furthermore, we analyzed differences in IFN-γ production by 
mononuclear cells isolated from LN and PB using the ELISPOT 
assay. Previous studies have shown that this assay shows impor-
tant correlations with regard to rejection and graft function after 
RT (44–47). However, we saw no differences with regard to IFN-
γ-producing cells from both compartments. On the other hand, 
we saw that production of IFN-γ and granzyme B was higher by 
PBMCs after 6 days of stimulation. Again, this is probably due 
to the increased presence of more differentiated cells within PB 
compared with LN (12). Next to this, proliferation of T  cells 
upon stimulation with alloantigens was also similar between 
the two compartments. This means that LNMCs have a similar 
FigUre 5 | IFN-γ, TNF-α, and granzyme B production after allogeneic stimulation. (a) The number of IFN-γ spots per 100,000 cells by LNMCs and PBMCs after 
allogeneic stimulation for 1 day is shown. The production of (B) TNF-α, (c) IFN-γ, and (D) granzyme B (pg/mL) by LNMCs and PBMCs after allogeneic stimulation 
for 6 days is shown. Data are shown as individual points and medians. Significant differences were calculated and shown (*p < 0.05, **p ≤ 0.01, ***p ≤ 0.001). 
IFN-γ, interferon-gamma; LNMCs, lymph node mononuclear cells; PBMCs, peripheral blood mononuclear cells; TNF-α, tumor necrosis factor-alpha.
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FigUre s1 | Analysis of proliferation after allogeneic stimulation of PBMCs and 
LNMCs. An example of the gating strategy is shown. The left column represents 
the analysis of LNMCs, while the right column shows the analysis of PBMCs after 
allogeneic stimulation. From top to bottom: first, lymphocytes were selected 
based on the forward and sideward scatter. Then, living CD3+ T cells were 
selected from these lymphocytes. The CD3+ T cells were then further divided into 
CD4+ and CD8+ T cells. Each population was then further dissected into different 
subsets using CCR7 and CD45RO. Only CD4+ T cells are shown, but the same 
analysis was applied on CD8+ T cells. The bottom graphs show an example of 
the analysis of proliferation after allogeneic stimulation with CFSE dilution. CFSE, 
carboxyfluorescein succinimidyl ester; LNMCs, lymph node mononuclear cells; 
PBMCs, peripheral blood mononuclear cells.
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